Latest market price
17.85
-0.88-4.70%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | 0.06 | Insider Own | 14.55% | Shs Outstand | 61.22M | Perf Week | -7.22% |
| Market Cap | 1.09B | Forward P/E | 40.02 | EPS next Y | 0.45 | Insider Trans | -5.14% | Shs Float | 4.70M | Perf Month | -12.37% |
| Enterprise Value | 870.72M | PEG | — | EPS next Q | 0.07 | Short Float | — | Perf Quarter | -11.55% | ||
| Income | 4.00M | P/S | 3.52 | EPS this Y | — | Short Ratio | 5.90 | Perf Half Y | 13.55% | ||
| Sales | 310.00M | P/B | 4.32 | EPS next Y | 35.68% | ROA | 1.31% | Short Interest | 8.35M | Perf YTD | 13.12% |
| Book/sh | 4.13 | P/C | 4.92 | EPS next 5Y | — | ROE | 1.84% | 52W High | 26.13 -31.69% | Perf Year | -26.42% |
| Cash/sh | 3.63 | P/FCF | 49.67 | EPS past 3/5Y | — | ROIC | -0.18% | 52W Low | 10.28 73.64% | Perf 3Y | — |
| Dividend Est. | — | EV/EBITDA | 79.16 | Sales past 3/5Y | 42.95% — | Gross Margin | 68.19% | Volatility | 4.97% 5.16% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 2.81 | EPS Y/Y TTM | — | Oper. Margin | -0.15% | ATR (14) | 1.02 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 3.85 | Sales Y/Y TTM | 47.62% | Profit Margin | 1.39% | RSI (14) | 38.89 | Recom | 2.15 |
| Dividend Gr. 3/5Y | — | Current Ratio | 3.91 | EPS Q/Q | 266.67% | SMA20 | -7.83% | Beta | 1.27 | Target Price | 25.88 |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | 44.26% | SMA50 | -13.47% | Rel Volume | 0.71 | Prev Close | 18.73 |
| Employees | 946 | LT Debt/Eq | 0.00 | Earnings | Nov 05 | SMA200 | 0.87% | Avg Volume | 1.33M | Price | 17.85 |
| IPO Date | Jun 06, 2025 | Option/Short | No / Yes | EPS/Sales Surpr. | 141.16% 9.74% | Net Debt/EBITDA | -20.18 | Volume | 948,378 | Change | -4.70% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-11-26 | Reiterated | Barclays | Overweight | $25 → $27 |
| Aug-12-26 | Reiterated | Robert W. Baird | $15 → $25 | |
| Aug-10-26 | Reiterated | BTIG | Buy | $30 → $35 |
| Aug-07-26 | Reiterated | BMO Capital | Outperform | $18 → $24 |
| Aug-03-26 | Reiterated | Barclays | Overweight | $22 → $25 |
| Jul-21-26 | Reiterated | Canaccord Genuity | Buy | $24 → $28 |
| Jul-17-26 | Initiated | BTIG | Buy | $30 |
| Jun-22-26 | Reiterated | Morgan Stanley | Overweight | $32 → $30 |
| May-08-26 | Reiterated | Canaccord Genuity | Buy | $22 → $24 |
| May-08-26 | Reiterated | Evercore ISI Group | Outperform | $15 → $20 |
Latest News· Times ET
Oct-28-26
Oct-22-26
Oct-22-2612:17PM
Oct-20-26
Oct-20-2609:00AM
Oct-13-26
Oct-13-2609:05AM
Oct-09-26
Oct-05-26
Sep-28-26
Sep-28-2604:00AM
03:23AM
Sep-26-26
Sep-26-2604:16AM
Sep-23-26
Sep-11-26
04:17AM
Omada Health, Inc. (OMDA) Analyst/Investor Day Transcriptseekingalpha.com
Sep-10-26
Sep-10-2609:00AM
Sep-09-26
Sep-09-2609:01AM
Company
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | |
|---|---|---|---|---|---|---|
| Total Revenue | 310 | 260 | 170 | 123 | — | |
| Cost of Goods Sold Incl. D&A | 98 | 89 | 67 | 53 | — | |
| Gross Profit | 212 | 171 | 103 | 70 | — | |
| Selling, General and Administrative Excl. Other | 125 | 142 | 111 | 102 | — | |
| Research and Development | 38 | 41 | 36 | 34 | — | |
| Other Operating Expense | 48 | 0 | 0 | 0 | — | |
| Operating Income | -1 | -12 | -44 | -66 | — | |
| Interest Expense | 0 | 3 | 5 | 5 | — | |
| Unusual Expense | — | — | — | — | — | |
| Non-Operating Income (Expense) | 6 | 2 | 1 | 3 | — | |
| Net Income Before Taxes | 4 | -13 | -47 | -68 | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | |
| Consolidated Net Income | 4 | -13 | -47 | -68 | — | |
| Net Income From Continuing Operations | 4 | -13 | -47 | -68 | — | |
| Net Income | 4 | -13 | -47 | -68 | — | |
| EPS (Recurring) | 0.07 | -0.22 | -0.85 | -1.21 | — | |
| EPS (Basic, Before Extraordinaries) | 0.07 | -0.22 | -0.85 | -1.21 | — | |
| EPS (Diluted) | 0.06 | -0.22 | -0.85 | -1.21 | — | |
| EBITDA | 11 | -5 | -38 | -58 | — | |
| Other After Tax Adjustments | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | |
| Price To Earnings Ratio | 297.50 | — | — | — | — | |
| Price To Sales Ratio | 3.45 | 3.52 | — | — | — | |
| Gross Margin | 68.39 | 65.77 | 60.59 | 56.91 | — | |
| Operating Margin | -0.32 | -4.62 | -25.88 | -53.66 | — | |
| Net Margin | 1.29 | -5.00 | -27.65 | -55.28 | — | |
| Shares Outstanding | 60 | 58 | 56 | 56 | — | |
| Market Capitalization | 1,071 | 915 | — | — | — | |
| Operating Lease Expense | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Duffy Sean P. | Chief Executive Officer | Oct 01 '26 | Option Exercise | 6.43 | 17,258 | 111,054 | 399,852 | Oct 05 |
| Duffy Sean P. | Chief Executive Officer | Oct 01 '26 | Sale | 20.68 | 17,258 | 356,916 | 382,594 | Oct 05 |
| Duffy Sean P. | Chief Executive Officer | Sep 10 '26 | Sale | 21.87 | 14,960 | 327,197 | 382,594 | Sep 14 |
| Cook Steven L. | Chief Financial Officer | Sep 10 '26 | Sale | 21.86 | 6,800 | 148,640 | 173,906 | Sep 14 |
| Shao Wei-Li | President | Sep 10 '26 | Sale | 21.85 | 4,036 | 88,206 | 295,313 | Sep 14 |
| Gracey Craig | Chief Accounting Officer | Sep 09 '26 | Sale | 21.73 | 644 | 13,995 | 14,412 | Sep 11 |
| Shao Wei-Li | President | Aug 12 '26 | Sale | 25.02 | 18,284 | 457,405 | 307,372 | Sep 04 |
| Duffy Sean P. | Chief Executive Officer | Sep 01 '26 | Option Exercise | 6.98 | 21,572 | 150,657 | 433,433 | Sep 03 |
| Duffy Sean P. | Chief Executive Officer | Sep 01 '26 | Sale | 23.62 | 21,572 | 509,465 | 411,861 | Sep 03 |
| Cook Steven L. | Chief Financial Officer | Aug 27 '26 | Sale | 25.00 | 1,108 | 27,700 | 187,209 | Aug 31 |
| Cook Steven L. | Chief Financial Officer | Aug 27 '26 | Option Exercise | 8.28 | 1,108 | 9,174 | 188,317 | Aug 31 |
| Cook Steven L. | Chief Financial Officer | Aug 11 '26 | Option Exercise | 8.28 | 1,607 | 13,306 | 188,816 | Aug 12 |
| Cook Steven L. | Chief Financial Officer | Aug 11 '26 | Sale | 25.01 | 1,607 | 40,197 | 187,209 | Aug 12 |
| Gracey Craig | Chief Accounting Officer | Aug 10 '26 | Option Exercise | 6.57 | 1,042 | 6,846 | 16,483 | Aug 12 |
| Gracey Craig | Chief Accounting Officer | Aug 10 '26 | Sale | 25.00 | 1,042 | 26,050 | 15,441 | Aug 12 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.